<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">From the collaborated evidence it is clear that ZIKV-RT-PCR has the desired specificity and sensitivity for detection on applicable flavivirus based on clinical symptoms observed (
 <xref rid="bb0245" ref-type="bibr">Robin and Mouchet, 1974</xref>, 
 <xref rid="bb0105" ref-type="bibr">Hegde et al., 2015</xref>, 
 <xref rid="bb0310" ref-type="bibr">Weaver and Forrester, 2015</xref>, 
 <xref rid="bb0075" ref-type="bibr">Faye et al., 2013</xref>, 
 <xref rid="bb0155" ref-type="bibr">Lanciotti et al., 2008</xref>). In its enhancement and scaling up as a screening technique, complementing more funding and investment in novel, safe and efficacious therapeutics agents and vaccines in meeting the vulnerable population and travel medicine immunization programs hopes and needs will be of immense benefit to cases profiling and management (
 <xref rid="bb0050" ref-type="bibr">Chang et al., 2015</xref>, 
 <xref rid="bb0005" ref-type="bibr">Abraham et al., 2015</xref>, 
 <xref rid="bb0235" ref-type="bibr">Petersen et al., 2016b</xref>).
</p>
